HDAC Inhibitors Are Class Drugs That Restrict The Growth Of Tumor Cells

 

HDAC Inhibitors

HDAC Inhibitors are a new class of anti-cancer agents that have recently been shown to induce apoptosis and cell cycle arrest in cancer cells. Several of these drugs are currently in clinical trials for the treatment of a variety of cancers, and some are also being investigated as possible treatment options for a range of other diseases. These include inflammatory and muscular dystrophies as well as autoimmune disorders.

The anti-cancer activity of HDAC Inhibitors is largely dependent on their ability to inhibit epigenetic changes. Thus, they should be used in combination with other agents to maximize their anti-cancer efficacy and safety.

Inhibitors of HDACs can be divided into three major groups: hydroxamic acid-based pan-HDAC inhibitors, aliphatic acids, and cyclic peptides. Inhibitors of HDACs that are selective to classes I and II are commonly referred to as cyclic peptides, while inhibitors of HDACs that are class III are known as aliphatic acids.

The most common class of HDAC Inhibitors is the hydroxamic acid-based group that includes suberoylanilide hydroxamic acid (SAHA/Vorinostat/Zolinza), trichostatin A (TSA), and PXD-101, all of which can inhibit HDACs in a cytosolic as well as a nuclear fashion. Some of these compounds, including SAHA and TSA, are currently in clinical development for cancer treatment, and others, such as MS-275 and MGCD0103, are in preclinical testing.

HDAC Inhibitors are based on a ring system, in which a methyl group, usually a sulfydryl group, is linked to a zinc-containing active site pocket. These molecules inhibit class I and II HDACs selectively in cell-free assays.

They have very low toxicity and are well tolerated, but they have limited clinical efficacy in treating a variety of different cancers. Because of the wide range of tumor types and the complex pathways that govern their response to HDAC inhibition, a broader understanding of these drugs' mechanism of action is needed to determine their effectiveness in treating other diseases



Comments

Popular posts from this blog

Ultrasonic Sensors: Revolutionizing Distance Measurement And Object Detection

Acai Berry Market Trends: From Smoothie Bowls To Beauty Products

The Rise Of Organic Tobacco: A Healthier Alternative To Traditional Cigarettes